How Much Does The TdVax Vaccine Cost? 2026 Pricing, Insurance, And Savings Guide

Understanding immunization costs can prevent unexpected medical bills, particularly when you need timely wound care or routine preventative maintenance. TdVax is an intramuscular injection formulated to protect individuals aged seven and older against both tetanus and diphtheria. While closely related to Tdap formulations, TdVax contains tetanus and diphtheria toxoids without the pertussis component, serving primarily as a decennial booster or an immediate post-exposure prophylaxis for dirty wounds.

Retail cash prices, insurance classifications, administrative fees, and manufacturer supply dynamics all dictate what you pay at the pharmacy counter or medical clinic. Navigating coverage rules under commercial health plans, Medicare Part D, and Medicaid is essential for keeping out-of-pocket expenses at zero or minimizing out-of-network clinic charges.

Retail Cash Pricing for TdVax Across National Pharmacies

For uninsured individuals or patients electing to pay without health benefits, the out-of-pocket cash cost for the TdVax vaccine in 2026 generally ranges between $45 and $95 per single dose. This total cost includes two distinct charges: the acquisition cost of the biological agent itself and the administration fee billed by the dispensing provider or clinical pharmacist.

Retail community pharmacies frequently stock TdVax alongside Tdap formulations such as Boostrix and Adacel. However, pricing structures vary depending on pharmacy contracts, geographic wholesale distribution terms, and clinical administration surcharges.

Community retail pharmacies represent the most accessible option for non-emergency decennial boosters. When receiving a dose at an urgent care facility or hospital emergency room following an acute injury, the vaccine itself is billed alongside clinical evaluation codes, resulting in significantly higher facility charges that elevate total billing beyond standard retail figures.

Insurance Coverage Frameworks and Out-of-Pocket Rules

Under federally mandated healthcare frameworks, patient cost-sharing for vaccines depends heavily on whether the shot is administered as preventive maintenance or reactive post-exposure medical treatment.

Commercial and Private Insurance (ACA Mandate)

The Affordable Care Act (ACA) requires all non-grandfathered private health insurance plans to cover vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) without charging a copayment, co-insurance, or deductible.

For routine ten-year boosters, an in-network provider must administer TdVax at $0 cost to the insured individual. However, two conditions void this guarantee:

1. Out-of-Network Administration: Receiving the vaccine from an out-of-network provider or non-contracted pharmacy exposes you to balance billing and standard out-of-network cost-sharing.
2. Coding Discrepancies During Acute Wound Care: If you visit a physician to treat a deep puncture wound and receive TdVax, the clinic may submit the administration under an acute treatment diagnostic code rather than a routine preventive code, applying your standard office copay or deductible.

Medicare Coverage Rules (Part B vs. Part D)

Medicare coverage rules for tetanus-containing vaccines depend entirely on medical necessity:

• Medicare Part D: Following the permanent implementation of the Inflation Reduction Act vaccine provisions, all commercial Medicare Part D prescription drug plans cover ACIP-recommended vaccines with a mandatory $0 copay. Routine preventive TdVax boosters are billed directly through Part D at contracted retail pharmacies.
• Medicare Part B: Part B only covers tetanus immunization if it is administered directly as part of active, emergency medical treatment for an injury, such as a rusty puncture wound, animal bite, or severe burn. Under Part B, routine preventive boosters are excluded, meaning claims submitted to Part B for scheduled maintenance will be denied.

Medicaid and State Programs

Adult Medicaid coverage for ACIP-recommended vaccines is mandatory across all standard state Medicaid programs under federal parity statutes. Beneficiaries accessing participating in-network health centers, federally qualified health centers (FQHCs), or contracted pharmacies pay $0 for TdVax. Uninsured children under the age of 19 qualify for the Vaccines for Children (VFC) program, which provides federally purchased antigens to participating pediatric clinics without vaccine acquisition costs.

Medical Coding and Billing Specifications

To avoid surprise balance billing, healthcare providers and billing departments utilize specific standardized codes when submitting claims for TdVax procurement and intramuscular delivery. Verifying these codes with your plan's claims processor before an appointment confirms pre-adjudication authorization.

• Current Procedural Terminology (CPT) Code: 90714 — Tetanus and diphtheria toxoids (Td) adsorbed, preservative-free, when administered to individuals 7 years or older, for intramuscular use.
• Administration CPT Code: 90471 — Immunization administration (percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid).
• National Drug Code (NDC): 14362-0111-04 (Carton of 10 single-dose vials) or 14362-0111-01 (Single vial dose).
• ICD-10 Preventive Diagnosis Code: Z23 — Encounter for immunization.
• ICD-10 Post-Exposure Diagnosis Codes: S-category puncture and laceration codes (e.g., S61.209A for unspecified puncture wound of finger with foreign body).

When a claim pairs CPT 90714 with diagnosis code Z23, commercial billing algorithms automate complete coverage without patient liability. If paired with an acute injury trauma code, billing systems route the charge through deductible and co-insurance adjudication matrices.

Clinical Comparison: TdVax Versus Alternative Tetanus Formulations

Understanding the pharmacological differences between available tetanus toxoid combinations helps clarify why your healthcare provider selects TdVax over alternatives like Adacel, Boostrix, or Tenivac.

+----------------------------------------------------------------------------------------------------+ | FORMULATION COMPARISON TABLE | +-------------------+-----------------+---------------------------+----------------------------------+ | Vaccine Name | Type | Manufacturer | Active Target Antigens | +-------------------+-----------------+---------------------------+----------------------------------+ | TdVax | Td | MassBiologics / Grifols | Tetanus, Diphtheria | | Tenivac | Td | Sanofi Pasteur | Tetanus, Diphtheria | | Adacel | Tdap | Sanofi Pasteur | Tetanus, Diphtheria, Pertussis | | Boostrix | Tdap | GlaxoSmithKline | Tetanus, Diphtheria, Pertussis | +-------------------+-----------------+---------------------------+----------------------------------+

ACIP guidelines stipulate that adults who have never received a dose of Tdap should receive one dose of Tdap instead of TdVax to establish pertussis immunity. Following that initial Tdap vaccination, subsequent routine boosters administered every ten years may utilize either TdVax (Td) or Tdap interchangeably.

Proven Strategies to Lower Out-of-Pocket Expenses

Uninsured patients, underinsured individuals with high-deductible plans, or those facing unexpected out-of-network clinical bills can leverage several financial routes to lower vaccine costs:

1. Prescription Discount Platforms: Digital pharmacy discount cards (such as GoodRx, SingleCare, or Optum Perks) offer negotiated cash pricing on CPT 90714 and its corresponding NDC. Using these tools typically reduces the vaccine drug cost to $35–$50 at major retail chains. Confirm that the pharmacy waives or bundles the injection administration fee alongside the card price.
2. County and Municipal Health Departments: Local government health agencies receive public health subsidies to supply adult immunizations at steep discounts. Administrative charges often operate on a sliding fee scale linked directly to local federal poverty line benchmarks, with fees waived entirely upon financial disclosure.
3. Federally Qualified Health Centers (FQHCs): FQHCs receive federal funding under Section 330 of the Public Health Service Act. These centers offer comprehensive clinical services, including preventive vaccinations, priced strictly according to patient income tiers.
4. Manufacturer Direct Programs: Although MassBiologics produces TdVax primarily for institutional distribution, clinical safety-net purchasing programs (such as 340B Drug Pricing entities) acquire the product at statutory wholesale discount pricing, passing savings down to eligible community clinic patients.
5. Retail Walk-In Clinics Over Emergency Rooms: If you require a tetanus booster for a non-life-threatening, clean laceration or minor puncture, opt for a retail pharmacy or walk-in urgent clinic over an emergency department. Emergency rooms incorporate triage fees and facility level charges that can escalate an otherwise $70 immunization into an invoice exceeding $1,000.

What to Expect: Administration and Clinical Workflow

Receiving TdVax involves a standardized clinical protocol to verify immunological appropriateness and minimize adverse events.

Clinical Assessment Protocol

Before administration, the clinician must confirm patient age, history of hypersensitivity to tetanus or diphtheria toxoids, and any prior occurrence of Guillain-Barré syndrome or brachial neuritis within six weeks of a previous tetanus vaccine. Moderate or severe acute illness generally warrants deferring vaccination until symptoms resolve.

Following clearance, the clinical procedure follows several defined steps:

1. Inspection and Preparation: The clinician visually inspects the single-dose 0.5 mL vial. TdVax appears as a turbid, white liquid suspension; the provider shakes the vial thoroughly to re-suspend the antigen particles evenly.
2. Site Selection: The deltoid muscle of the upper arm serves as the preferred anatomical target for intramuscular delivery in adults and older children.
3. Aseptic Injection: The provider sterilizes the skin, inserts a 22- to 25-gauge needle at a 90-degree angle directly into the muscle mass, and injects the complete 0.5 mL volume.
4. Post-Vaccination Monitoring: Patients are generally observed for 10 to 15 minutes to evaluate for rare acute events such as vasovagal syncope or anaphylaxis. Mild local reactions, including pain, erythema, and mild swelling at the injection site, represent normal responses and resolve within 48 to 72 hours.

Frequently Asked Questions

What is the average out-of-pocket cash cost for the TdVax vaccine without insurance?

A complete out-of-pocket cash payment for TdVax averages between $60 and $95 at national community pharmacies. This price includes both the biological toxoid suspension and the injection administration fee.

Pricing depends on the clinical setting. Retail pharmacies provide the most affordable out-of-pocket rates, whereas urgent care centers and emergency departments assess additional facility and evaluation charges that substantially increase the total bill.

Is TdVax free under standard commercial health insurance plans?

Yes, TdVax is covered at 100% with no patient deductible, copayment, or co-insurance under non-grandfathered private plans when billed as a preventive booster through an in-network provider.

If the injection is administered by an out-of-network provider or billed under an acute injury diagnosis code at an urgent care center, the ACA preventive mandate may not apply, and standard plan cost-sharing will determine your expense.

Does Medicare Part B or Part D cover the cost of TdVax?

Medicare Part D covers routine TdVax boosters at a $0 copay, while Medicare Part B only covers the vaccine when administered as medically necessary wound treatment following an injury.

To ensure your routine booster is fully covered with zero out-of-pocket liability, obtain the shot at an in-network Medicare Part D retail pharmacy rather than an outpatient medical clinic that primarily bills Part B.

What is the primary difference between TdVax and a Tdap vaccine?

TdVax protects against tetanus and diphtheria (Td), whereas Tdap protects against tetanus, diphtheria, and acellular pertussis (whooping cough).

Adults who have never received an adult pertussis booster require Tdap. Once pertussis immunity is established, ACIP guidelines allow either TdVax or Tdap to serve as subsequent ten-year boosters or post-exposure prophylaxis.

Can I get TdVax at a local pharmacy, or do I need to see a physician?

Certified immunizing pharmacists at major retail chains can assess your eligibility and administer TdVax directly under standing orders without an individualized physician prescription in most states.

Calling ahead to verify active inventory is recommended. Some locations selectively stock Tdap (such as Boostrix or Adacel) rather than dual-antigen Td vaccines like TdVax, though both fulfill standard decennial booster requirements.

Take Action on Your Immunization Needs

Maintaining active protection against tetanus and diphtheria is an ongoing healthcare priority. If your last tetanus booster was administered more than ten years ago, or more than five years ago in the presence of a dirty or puncture-prone wound, check your state immunization registry or reach out to your local healthcare provider.

Schedule your appointment through an in-network community pharmacy or primary care physician to secure full preventative insurance coverage at $0, or contact your county health department to access sliding-scale fee assistance.